Skip to main content

Parliament dissolved ahead of election

The Scottish Parliament is now dissolved ahead of the election on Thursday 7 May 2026.

During dissolution, there are no MSPs and no parliamentary business can take place.

For more information, please visit Election 2026

Loading…

Search

There are 15,359 results relating to "Medicin Viagra-m"

Order by |

Refine your search

Select from the available filters to refine your search


Available filters:

Can't find what you're looking for?

If you're having trouble finding the information you want, please contact [email protected].

Last updated: 2 April 2024

PB_2022_093

Cunninghame Graham and Scotland: Party, Prose and Political Aesthetic 25 May 2022 Fergus Ewing SNP Scotland’s Fair Share, the Potential of Solar Energy in Scotland th 26 May 2022 Sharon Dowey CON Marking the 40 Anniversary of the Liberation of the Falkland Islands 31 May 2022 Colin Smyth LAB Ethical Principles in Wildlife Management 1 June 2022 Collette SNP Access to Cannabis-based Products for Stevenson Medicinal...
Last updated: 2 April 2024

PB_2022_037

S6M-03022: Fulton MacGregor: Phenylketonuria (PKU) - That the Parliament recognises that phenylketonuria (PKU) is a rare metabolic condition where the body cannot process phenylalanine, an amino acid found in protein foods; understands that prolonged exposure to protein in their diet can result in people with PKU experiencing significant health issues, including brain damage; further understands that, at present, children and adults with PKU must follow an extreme dietary regime by cutting out almost all protein, weighing food and taking supplements, leaving them unable to make any spontaneous food choices or enjoy the same food as other people; understands that the drug, sapropterin, can assist in giving eligible people with PKU, including those in the Coatbridge and Chryston constituency, and across Scotland, some normality in their diet, and that the manufacturer of Kuvan, BioMarin Pharmaceutical, previously had an application for the drug turned down by the Scottish Medicines...
Last updated: 2 April 2024

PB_2022_031

S6M-03022: Fulton MacGregor: Phenylketonuria (PKU) - That the Parliament recognises that phenylketonuria (PKU) is a rare metabolic condition where the body cannot process phenylalanine, an amino acid found in protein foods; understands that prolonged exposure to protein in their diet can result in people with PKU experiencing significant health issues, including brain damage; further understands that, at present, children and adults with PKU must follow an extreme dietary regime by cutting out almost all protein, weighing food and taking supplements, leaving them unable to make any spontaneous food choices or enjoy the same food as other people; understands that the drug, sapropterin, can assist in giving eligible people with PKU, including those in the Coatbridge and Chryston constituency, and across Scotland, some normality in their diet, and that the manufacturer of Kuvan, BioMarin Pharmaceutical, previously had an application for the drug turned down by the Scottish Medicines...
Last updated: 2 April 2024

PB_2022_025

S6M-03022: Fulton MacGregor: Phenylketonuria (PKU) - That the Parliament recognises that phenylketonuria (PKU) is a rare metabolic condition where the body cannot process phenylalanine, an amino acid found in protein foods; understands that prolonged exposure to protein in their diet can result in people with PKU experiencing significant health issues, including brain damage; further understands that, at present, children and adults with PKU must follow an extreme dietary regime by cutting out almost all protein, weighing food and taking supplements, leaving them unable to make any spontaneous food choices or enjoy the same food as other people; understands that the drug, sapropterin, can assist in giving eligible people with PKU, including those in the Coatbridge and Chryston constituency, and across Scotland, some normality in their diet, and that the manufacturer of Kuvan, BioMarin Pharmaceutical, previously had an application for the drug turned down by the Scottish Medicines...
Last updated: 17 April 2023

Petition PE1758 GBGB response 6 April 2023

GBGB will commission Dr Richard Payne, Associate Professor of Veterinary Anatomy, School of Veterinary Medicine and Science, University of Nottingham, and scientific and veterinary advisor to GBGB’s Welfare and Veterinary Standing Committee to undertake a review of where an evidence base already exists and where further research is needed around track desig...
Last updated: 6 October 2022

Biodiversity Strategy Consultation letter 17 June 2022

It is this web of relationships between inter-dependent organisms and the environment which provides the benefits that people get from nature, such as food, medicines, fibre and other natural materials – all of the things we need to survive.
Last updated: 6 October 2022

Petition PE1758 GREY2K USA Worldwide submission of 11 April 2022

In Queensland, a greyhound $24.38 million (€23 million) in total racing turnover tested positive for Desvenlafaxine, a drug normally 102 in 2019, a decline of 30.03% since 2010. used to treat depression and which isn’t used at all 99 In Macau’s final full year of racing, 2017, $26.16 in veterinary medicine. In Western Australia, a million (MOP218 million) w...
Last updated: 6 October 2022

Petition PE1758 submission from GREY2K USA Worldwide 11 April 2022

In Queensland, a greyhound $24.38 million (€23 million) in total racing turnover tested positive for Desvenlafaxine, a drug normally 102 in 2019, a decline of 30.03% since 2010. used to treat depression and which isn’t used at all 99 In Macau’s final full year of racing, 2017, $26.16 In Western Australia, a in veterinary medicine. million (MOP218 million) w...
Official Report Meeting date: 3 September 2019

Health and Sport Committee 03 September 2019

I will carry on with questions on finance before moving to other board evidence that was submitted. New medicine costs were mentioned. Your evidence pointed to potential cost containment but, in the detail that was provided to us, the spend on new medicines was just £34,621.
Questions and Answers Date answered: 4 March 2016

S4W-29802

Out of hours cover is provided by the medicine for the elderly junior doctors who are on call, and also the hospital at night (HAN) team based at Glasgow Royal Infirmary (GRI).

Can't find what you're looking for?

If you're having trouble finding the information you want, please contact [email protected].